Research Article
Biomarkers for Diagnosis and Prediction of Outcomes in Contrast-Induced Nephropathy
Table 1
Participants’ demographic and clinical characteristics.
| | Characteristic | CIN+ (30) | CIN− (60) | value |
| | Age (years), median | 56.5 (41–62.5) | 47 (34.5–60.5) | 0.19 | | Gender Male, n (%) | 17 (34.6) | 32 (65.3) | 0.82 | | Female, n (%) | 13 (31.7) | 28 (682) | | Hypertension, n (%) | Yes | 9 (47.3) | 10 (52.6) | 0.18 | | No | 21 (29.5) | 50 (70.4) | | Diabetes mellitus, n (%) | Yes | 4 (33.3) | 8 (66.7) | 0.62 | | No | 26 (33.3) | 52 (66.7) | | Cancer, n (%) | Yes | 11 (30.5) | 25 (69.4) | 0.82 | | No | 19 (35.1) | 35 (64.8) | | HIV positive, n (%) | Yes | 6 (27.3) | 16 (72.7) | 0.41 | | No | 24 (35.3) | 44 (64.7) | | Baseline urea (mmol/L), median | 4.9 (3.9–7.7) | 4.1 (3.3–6.2) | 0.19 | | Baseline creatinine (μmol/L), median | 69 (53–96) | 67 (52–84.5) | 0.69 | | Baseline eGFR (ml/min/1.73 m2), median | 107 (72–133) | 113 (88–136) | 0.47 | | Baseline eGFR <60 ml/min/1.73 m2, n (%) | Yes | 2 (50.0) | 2 (50.0) | 0.59 | | No | 28 (32.5) | 58 (67.4) | | Postcreatinine (μmol/L), median | 104 (85–156) | 63.5 (46.5–76.5) | <0.001 | | Serum albumin (g/dL), mean | 33.6 (SD 7.6) | 36.6 (SD 7.0) | 0.07 | | Haemoglobin (g/dL), mean | 11 (SD 2.9) | 12.1 (SD 2.4) | 0.06 | | Diastolic blood pressure (mmHg), median | 72 (66–84) | 73 (67–83) | 0.76 | | Systolic blood pressure (mmHg), mean | 116.3 (SD 15.9) | 119.7 (SD 14.4) | 0.37 | | Type of procedure, n (%) | IV | 26 (33.1) | 51 (66.2) | 0.53 | | Arterial | 4 (30.7) | 9 (69.2) | | Duration (days), median | 16.5 (10–23) | 12 (9–21) | 0.42 | | Mortality, n (%) | Yes | 7 (46.7) | 8 (53.3) | 0.24 | | No | 23 (30.7) | 52 (69.3) |
|
|
HIV, human immunodeficiency virus; eGFR, estimated glomerular filtration rate; CIN, contrast-induced nephropathy; SD, standard deviation.
|
